Virtual Medicinal Product (VMP)
-
Bosentan 62.5mg tablets
Name Details
Current Name
Bosentan 62.5mg tablets
|
Start Date
11-08-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
C02KX01
BNF |
Current BNF
02050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02050100
|
Start Date
03-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39734011000001108 |
27-05-2021 |
|
407815004 |
17-01-2007 |
26-05-2021 |
385562001 |
09-08-2005 |
16-01-2007 |
4776711000001102 |
11-08-2003 |
08-08-2005 |
VMP Ingredients
Name
Bosentan monohydrate
Basis of strength description
Based on Base Substance
BOSS
Bosentan
Strength and UOM (Nmr)
62.5
Strength and UOM (Dmr)
Parent Products
-
VTM
Bosentan
-
VMP
(Current) Bosentan 62.5mg tablets
Virtual Medicinal Product Pack (VMPP) Information